SCHEMBL25988487

SCHEMBL25988487

CC(C)c1nc(S(C)(=O)=O)ncc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLP1R P43220 1/20 0.36
TLR9 Q9NR96 3/20 0.34
NPC1 O15118 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TP53 P04637 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CDK1 P06493 3/20 0.33
CDK2 P24941 3/20 0.33
KDR P35968 2/20 0.33
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
RAB9A P51151 2/20 0.32
MITF O75030 1/20 0.32
S1PR4 O95977 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18539154 0.81 GLP1R (0.38) GLP1RTLR9NPC1ALDH1A1MAPT
SCHEMBL10582722 0.77 TP53 (0.41) TLR9NPC1ALDH1A1MAPTHTT
SCHEMBL18799333 0.75 TP53 (0.38) GLP1RTLR9NPC1ALDH1A1MAPT
SCHEMBL4068061 0.75 JAK1 (0.31) TLR9NPC1RAB9APAX8MEN1
SCHEMBL29495649 0.74 TP53 (0.42) TLR9NPC1ALDH1A1MAPTHTT
SCHEMBL9626944 0.74 TP53 (0.42) TLR9NPC1ALDH1A1MAPTHTT
SCHEMBL5189309 0.73 LRRK2 (0.37) GLP1RTLR9NPC1ALDH1A1MAPT
SCHEMBL15035940 0.72 ALDH1A1 (0.40) GLP1RTLR9NPC1ALDH1A1MAPT
SCHEMBL22400987 0.71 LMNA (0.43) TLR9NPC1ALDH1A1MAPTHTT
SCHEMBL27895448 0.71 TP53 (0.40) GLP1RTLR9NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST THRB, THRA, TSHR GLP1R 7/4885TLR9 1045/4885NPC1 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.